In this study, our in vitro and in vivo results demonstrated that the co-administration of Dox and PTX at the synergistic ratio (1∶1) via cMLVs efficiently suppressed P-gp expression in both wild-type and drug-resistant cancer cells. The gene discussed is PGP; the disease is cancer.